These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

186 related items for PubMed ID: 8971300

  • 1. Helicobacter pylori eradication using one-week low-dose lansoprazole plus amoxycillin and either clarithromycin or azithromycin.
    Cammarota G, Tursi A, Papa A, Montalto M, Veneto G, Cuoco L, Fedeli G, Gasbarrini G.
    Aliment Pharmacol Ther; 1996 Dec; 10(6):997-1000. PubMed ID: 8971300
    [Abstract] [Full Text] [Related]

  • 2. Polaprezinc, a mucosal protective agent, in combination with lansoprazole, amoxycillin and clarithromycin increases the cure rate of Helicobacter pylori infection.
    Kashimura H, Suzuki K, Hassan M, Ikezawa K, Sawahata T, Watanabe T, Nakahara A, Mutoh H, Tanaka N.
    Aliment Pharmacol Ther; 1999 Apr; 13(4):483-7. PubMed ID: 10215732
    [Abstract] [Full Text] [Related]

  • 3. Pantoprazole, amoxycillin and either azithromycin or clarithromycin for eradication of Helicobacter pylori in duodenal ulcer.
    Vcev A, Stimac D, Ivandić A, Vceva A, Takac B, Pezerović D.
    Aliment Pharmacol Ther; 2000 Jan; 14(1):69-72. PubMed ID: 10632647
    [Abstract] [Full Text] [Related]

  • 4. Helicobacter pylori eradication and ulcer healing with daily lansoprazole, plus 1 or 2 weeks co-therapy with amoxycillin and clarithromycin.
    Louw JA, Van Rensburg CJ, Moola S, Kotze D, Marks IN.
    Aliment Pharmacol Ther; 1998 Sep; 12(9):881-5. PubMed ID: 9768531
    [Abstract] [Full Text] [Related]

  • 5. Lansoprazole and secnidazole with clarithromycin, amoxycillin or pefloxacin in the eradication of Helicobacter pylori in a developing country.
    Ahuja V, Dhar A, Bal C, Sharma MP.
    Aliment Pharmacol Ther; 1998 Jun; 12(6):551-5. PubMed ID: 9678815
    [Abstract] [Full Text] [Related]

  • 6. Efficacy of 1 week omeprazole or lansoprazole-amoxycillin-clarithromycin therapy for Helicobacter pylori infection in the Japanese population.
    Miwa H, Nagahara A, Sato K, Ohkura R, Murai T, Shimizu H, Watanabe S, Sato N.
    J Gastroenterol Hepatol; 1999 Apr; 14(4):317-21. PubMed ID: 10207779
    [Abstract] [Full Text] [Related]

  • 7. Comparison of seven and fourteen days of lansoprazole, clarithromycin, and amoxicillin therapy for eradication of Helicobacter pylori: a report from India.
    Bhasin DK, Sharma BC, Ray P, Pathak CM, Singh K.
    Helicobacter; 2000 Jun; 5(2):84-7. PubMed ID: 10849056
    [Abstract] [Full Text] [Related]

  • 8. Comparison of omeprazole and lansoprazole in short-term triple therapy for Helicobacter pylori infection.
    Spinzi GC, Bierti L, Bortoli A, Colombo E, Fertitta AM, Lanzi GL, Venturelli R, Minoli G.
    Aliment Pharmacol Ther; 1998 May; 12(5):433-8. PubMed ID: 9663722
    [Abstract] [Full Text] [Related]

  • 9. High-dose proton pump inhibitor plus amoxycillin for the treatment or retreatment of Helicobacter pylori infection.
    Malaty H, el-Zimaity HM, Genta RM, Cole RA, Graham DY.
    Aliment Pharmacol Ther; 1996 Dec; 10(6):1001-4. PubMed ID: 8971301
    [Abstract] [Full Text] [Related]

  • 10. A randomized trial of lansoprazole, amoxycillin, and clarithromycin versus lansoprazole, bismuth, metronidazole and tetracycline in the retreatment of patients failing initial Helicobacter pylori therapy.
    Magaret N, Burm M, Faigel D, Kelly C, Peterson W, Fennerty MB.
    Dig Dis; 2001 Dec; 19(2):174-8. PubMed ID: 11549829
    [Abstract] [Full Text] [Related]

  • 11. Short-term triple therapy with lansoprazole 30 mg or 60 mg, amoxycillin and clarithromycin to eradicate Helicobacter pylori.
    Sieg A, Sellinger M, Schlauch D, Hörner M, Fuchs W.
    Aliment Pharmacol Ther; 1999 Jul; 13(7):865-8. PubMed ID: 10383519
    [Abstract] [Full Text] [Related]

  • 12. Three-day antibiotic therapy with azithromycin and tinidazole plus lansoprazole or pantoprazole to cure Helicobacter pylori infection: a pilot study.
    Cammarota G, Papa A, Cianci R, Cannizzaro O, Armuzzi A, Gasbarrini A, Addolorato G, Gasbarrini GB.
    Eur J Gastroenterol Hepatol; 1999 Mar; 11(3):247-50. PubMed ID: 10333196
    [Abstract] [Full Text] [Related]

  • 13. Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin.
    Furuta T, Shirai N, Takashima M, Xiao F, Hanai H, Sugimura H, Ohashi K, Ishizaki T, Kaneko E.
    Clin Pharmacol Ther; 2001 Mar; 69(3):158-68. PubMed ID: 11240980
    [Abstract] [Full Text] [Related]

  • 14. Low-dose lansoprazole and clarithromycin plus metronidazole vs. full-dose lansoprazole and clarithromycin plus amoxicillin for eradication of Helicobacter pylori infection.
    Bazzoli F, Zagari RM, Pozzato P, Fossi S, Ricciardiello L, Nicolini G, De Luca L, Berretti D, Alampi G, Di Pietro C, Morelli P, Roda E.
    Aliment Pharmacol Ther; 2002 Jan; 16(1):153-8. PubMed ID: 11856090
    [Abstract] [Full Text] [Related]

  • 15. Comparison of azithromycin and clarithromycin in triple therapy regimens for the eradication of Helicobacter pylori.
    Sullivan B, Coyle W, Nemec R, Dunteman T.
    Am J Gastroenterol; 2002 Oct; 97(10):2536-9. PubMed ID: 12385435
    [Abstract] [Full Text] [Related]

  • 16. [Lansoprazole: a review of its role in Helicobacter pylori eradication therapy].
    Gisbert JP.
    Rev Esp Enferm Dig; 1999 Feb; 91(2):133-43. PubMed ID: 10231305
    [Abstract] [Full Text] [Related]

  • 17. Effect of different proton pump inhibitors, differences in CYP2C19 genotype and antibiotic resistance on the eradication rate of Helicobacter pylori infection by a 1-week regimen of proton pump inhibitor, amoxicillin and clarithromycin.
    Kawabata H, Habu Y, Tomioka H, Kutsumi H, Kobayashi M, Oyasu K, Hayakumo T, Mizuno S, Kiyota K, Nakajima M, Kimoto K, Inokuchi H, Kawai K.
    Aliment Pharmacol Ther; 2003 Jan; 17(2):259-64. PubMed ID: 12534411
    [Abstract] [Full Text] [Related]

  • 18. Incidence of secondary Helicobacter pylori resistance to antibiotics in treatment failures after 1-week proton pump inhibitor-based triple therapies: a prospective study.
    Pilotto A, Franceschi M, Rassu M, Leandro G, Bozzola L, Furlan F, Di Mario F.
    Dig Liver Dis; 2000 Nov; 32(8):667-72. PubMed ID: 11142574
    [Abstract] [Full Text] [Related]

  • 19. Eradication rates of clarithromycin-resistant Helicobacter pylori using either rabeprazole or lansoprazole plus amoxicillin and clarithromycin.
    Murakami K, Sato R, Okimoto T, Nasu M, Fujioka T, Kodama M, Kagawa J, Sato S, Abe H, Arita T.
    Aliment Pharmacol Ther; 2002 Nov; 16(11):1933-8. PubMed ID: 12390102
    [Abstract] [Full Text] [Related]

  • 20. Impact of rabeprazole, a new proton pump inhibitor, in triple therapy for Helicobacter pylori infection-comparison with omeprazole and lansoprazole.
    Miwa H, Ohkura R, Murai T, Sato K, Nagahara A, Hirai S, Watanabe S, Sato N.
    Aliment Pharmacol Ther; 1999 Jun; 13(6):741-6. PubMed ID: 10383502
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.